Tuesday, July 5, 2022

MultiOmic Health and Mesh Bio to use AI to develop precision medicines

0
MultiOmic Health, an artificial intelligence-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, announced their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease.

QIMR Berghofer and Proteomics International agree exclusive deal

0
QIMR Berghofer has signed an exclusive worldwide licence agreement with Proteomics International Laboratories Ltd allowing the organisation to develop and commercialise a simple blood test for early detection of the most common form of oesophageal cancer.

Argenta announces the hire Paul Fry as its new Chief Financial Officer

0
Argenta announced that Paul Fry will join the company as its new CFO, starting immediately. To ensure a smooth transition, Paul will work closely with former CFO Chris O’Donnell until late August. The CFO role is being relocated from New Zealand to London to enable the CEO and CFO to work closely together in the same time zone, and to be closer to customers.

GC Aesthetics® announces its expansion into the Brazilian market

0
GC Aesthetics®, Inc. (GCA), a privately-held medical tech firm providing Women Healthcare Aesthetic and Reconstructive Solutions, has announced today, its growth and expansion plans for the Brazilian market, the second largest Breast Augmentation market in the world. GC Aesthetics® has been executing an ambitious journey repositioning the brand and portfolio to offer a smart, unique, and clinically proven safe range of products to meet the needs of Brazilian women and surgeons. The Brazilian growth strategy includes 2 main pillars.

HKSTP and BIVF team up to launch strategic co-Incubation programme

0
Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering research-driven biopharmaceutical firm, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation collaboration to nurture startups on R&D for infectious diseases and immunology.

Queensland company move-to-earn fitness craze hits international stage

0
A Queensland company is helping generate a new global fitness craze by working out that a workout can lead to bigger rewards than just better health. PUML is offering novel incentives and finding soaring demand for rewards for getting off the couch and getting moving.

INVL Baltic Sea Growth Fund to buy a modern Baltics care treatment centre

0
INVL Baltic Sea Growth Fund (the Fund), a private equity investment fund in the Baltic region, has announced that it has signed an agreement to acquire one of the most modern medical treatment centres in the Baltic region, located in Birštonas, Nemunas as well as the largest rehabilitation and post-acute care treatment centres in the Baltics, Eglės Sanatorija.

EnChroma expands to Australia and launches glasses for the colour blind

0
EnChroma, Inc. announced its expansion to Australia. Colour blindness affects one in 12 men (8%) and one in 200 women (0.5%); 350 million people worldwide, and one million Aussies. While people with normal colour vision see over one million shades of colour, while those with colour vision deficiency (CVD) only see an estimated 10% of hues and shades. Common colour confusions include green and yellow, gray and pink, purple and blue, red and brown.

Mind Medicine Australia hires Ronnie Figdor as its Chief Operating Officer

0
Mind Medicine Australia has appointed Ronnie Figdor OAM as its first Chief Operating Officer. Figdor, who has been lecturing in medical and business ethics for almost three decades, has a background in medical research, education, computing and management.

New alliance to fight biggest killer of middle-aged and young Australians

0
A new alliance of Australia’s leading heart experts, paramedics, CPR and victim family groups has met for the first time this week to take united action against a sinister type of heart problem that kills thousands of Australians each year – suddenly and without warning.